Back
Amgen Quote, Financials, Valuation and Earnings
Sponsored
AMGN
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47
AMGN
Amgen
Last Price:
280.01
Seasonality Move:
10.29%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.Amgen Price Quote
$280.01
-13.99 (-4.76%)
(Updated: November 26, 2024 at 5:55 PM ET)
Amgen Key Stats
Sell
47
Amgen (AMGN)
is a Sell
Day range:
$293.50 - $297.32
52-week range:
$260.68 - $346.85
Dividend yield:
3.06%
P/E ratio:
23.54
P/S ratio:
4.87
P/B ratio:
21%
Volume:
4.5M
Avg. volume:
2.6M
1-year change:
10.75%
Market cap:
$158B
Revenue:
$28.2B
EPS:
$7.81
How Much Does Amgen Make?
Is Amgen Growing As A Company?
Amgen Stock Price Performance
What Is Amgen 52-Week High & Low?
Amgen Price To Free Cash Flow
-
Is Amgen Stock Overvalued?
Amgen is trading at a price to free cash flow ratio of 25.23 -
Is Amgen Stock Undervalued?
Amgen EV to Free Cash Flow ratio is 33.33 -
What Is Amgen’s Price Earnings Growth Ratio?
AMGN PEG ratio is 0.00 -
Is Amgen Trading At A Premium To Earnings?
Amgen EV to EBIT ratio is 26.48
Is It Risky To Buy Amgen?
Is Amgen Cash Flow Positive?
Amgen Return On Invested Capital
Amgen Earnings Date & Stock Price
-
What Is Amgen's Stock Price Today?
A single share of AMGN can be purchased today for 294.00 -
What Is Amgen’s Stock Symbol?
Amgen trades on the S&P500 under the ticker symbol: AMGN -
When Is Amgen’s Next Earnings Date?
The next quarterly earnings date for Amgen is scheduled on February 6, 2025 -
When Is AMGN's next ex-dividend date?
Amgen's next ex-dividend date is November 18, 2024 -
How To Buy Amgen Stock?
You can buy Amgen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Amgen Competitors
Amgen Dividend Yield
Amgen Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 62.11% | 9.29% |
Revenue: | 23.18% | 0.05% |
Analyst Recommendations
Buy Recommendations: | 10 |
---|---|
Hold Recommendations: | 17 |
Sell Recommendations: | 2 |
Price Target: | 332.67 |
Upside from Last Price: | 13.15% |